Arrhythmogenic risk of late gadolinium enhancement in patients with hypertrophic cardiomyopathy: Burden and location?

[1]  J. Almeida,et al.  Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy. , 2020, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[2]  Y. Amano,et al.  Relationship of Nonseptal Late Gadolinium Enhancement to Ventricular Tachyarrhythmia in Hypertrophic Cardiomyopathy , 2017, Journal of computer assisted tomography.

[3]  Sabino Iliceto,et al.  Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death , 2015, Circulation.

[4]  W. Manning,et al.  Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy. , 2015, The American journal of cardiology.

[5]  L. Adler,et al.  Variable Cardiac 18FDG Patterns Seen in Oncologic Positron Emission Tomography Computed Tomography: Importance for Differentiating Normal Physiology From Cardiac and Paracardiac Disease , 2012, Journal of thoracic imaging.

[6]  I. Taniguchi,et al.  Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy. , 2011, Journal of cardiology.

[7]  H. E. Keurs.  Electromechanical coupling in the cardiac myocyte; stretch-arrhythmia feedback , 2011, Pflügers Archiv - European Journal of Physiology.

[8]  Lidia Chojnowska,et al.  Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. , 2010, European journal of radiology.

[9]  N. Smedira,et al.  Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. , 2009, Journal of the American College of Cardiology.

[10]  A. Gradman,et al.  From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. , 2006, Progress in cardiovascular diseases.

[11]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[12]  Heiko Mahrholdt,et al.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[13]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[14]  M Lei,et al.  Sudden cardiac death by Commotio cordis: role of mechano-electric feedback. , 2001, Cardiovascular research.

[15]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[16]  R. Kim,et al.  Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. , 2000, Journal of the American College of Cardiology.

[17]  D. Peters,et al.  Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. , 2011, Radiology.